0001209191-16-120554.txt : 20160516
0001209191-16-120554.hdr.sgml : 20160516
20160516214736
ACCESSION NUMBER: 0001209191-16-120554
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160516
FILED AS OF DATE: 20160516
DATE AS OF CHANGE: 20160516
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ChemoCentryx, Inc.
CENTRAL INDEX KEY: 0001340652
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943254365
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 850 MAUDE AVENUE
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
BUSINESS PHONE: 650-210-2900
MAIL ADDRESS:
STREET 1: 850 MAUDE AVENUE
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Edwards Thomas A.
CENTRAL INDEX KEY: 0001648283
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35420
FILM NUMBER: 161655988
MAIL ADDRESS:
STREET 1: C/O CHEMOCENTRYX, INC.
STREET 2: 850 MAUDE AVE.
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-05-16
0
0001340652
ChemoCentryx, Inc.
CCXI
0001648283
Edwards Thomas A.
C/O CHEMOCENTRYX, INC.
850 MAUDE AVENUE
MOUNTAIN VIEW
CA
94043
1
0
0
0
Common Stock
2016-05-16
4
P
0
25000
4.0485
A
41977
D
Reflects the weighted average sale price of the shares purchased. The shares were purchased in multiple trades at prices ranging from $4.035 to $4.05 per share, inclusive. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.
/s/ Susan M. Kanaya, as Attorney-in-Fact
2016-05-16